Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis.
Sungkanuparph
Somnuek
S
Jongwutiwes
Ubonvan
U
Kiertiburanakul
Sasisopin
S
D017088:AIDS-Related Opportunistic Infections / Q000139:chemically induced*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D003454:Cryptococcus / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007249:Inflammation / Q000139:chemically induced*; D053208:Kaplan-Meier Estimate; D008297:Male; D016919:Meningitis, Cryptococcal / Q000139:chemically induced / Q000150:complications*; D012008:Recurrence; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome; D013997:Time Factors; D016896:Treatment Outcome
D044966:Anti-Retroviral Agents; D018894:Reverse Transcriptase Inhibitors